Ligand Pharmaceuticals | 资产

Assets 更改 日
Amgen USD 92.98B 4.17B 2024-03
Arrowhead Research USD 955.15M 328.86M 2024-03
Baxter International USD 27.79B 488M 2024-03
Bristol-Myers Squibb USD 99.03B 7.77B 2024-03
Eli Lilly USD 63.94B 6.03B 2024-03
Gilead Sciences USD 56.29B 5.83B 2024-03
GlaxoSmithKline GBP 58.51B 494M 2024-03
Glaxosmithkline GBP 58.51B 494M 2024-03
Insmed USD 1.16B 170.74M 2024-03
Ionis Pharmaceuticals USD 2.76B 226.14M 2024-03
Ligand Pharmaceuticals USD 913.87M 126.65M 2024-03
MacroGenics USD 248.28M 50.13M 2024-03
Merck USD 105.85B 878M 2024-03
Pacira USD 1.58B 8.93M 2024-03
Pfizer USD 221.1B 6.07B 2024-03
Veracyte USD 1.2B 85.17M 2024-03



Ligand Pharmaceuticals 资产 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.